SUPRA SDRM® is a novel synthetic, guided wound closure matrix, 
built as a bimodal foam membrane structure for the management of
chronic wounds.

SUPRA SDRM® combines the benefits of the microporous structure
known from Suprathel® that builds a protective barrier allowing the wound to heal and additional large pores which were created to enable ingrowth of blood vessels.

SUPRA SDRM® is fully synthetic – no animal derived components – polylactic acid as the main component reduces the biologic risk.
No preparation of SUPRA SDRM® matrix is necessary. When applied to the wound SUPRA SDRM® adheres well to the wound bed without the need for direct fixation. SUPRA SDRM® becomes translucent after the application allowing healthcare professionals to easily assess the wound healing.

SUPRA SDRM® is available in multiple sizes and can be trimmed to meet the patient’s needs.


SUPRA SDRM® is indicated for use in the management of:

  • Pressure (stage I and IV) and venous Ulcers
  • Partial thickness burns
  • Ulcers caused by mixed vascular Etiologies
  • Trauma wounds
  • Venous stasis and diabetic ulcers
  • Surgical wounds
  • Partial and full thickness wounds

SUPRA SDRM® sizes are:

  Size   Units  Order-No.
  1 x 1 cm  1  310101-US
  18 mm  1  31D018-US
2 x 2 cm  1  310202-US
5.1 x 5.1 cm  1  310505-US
9 x 9 cm  1  310909-US
  9 x 12 cm  1  310912-US
18 x 9 cm  1  311809-US
18 x 18 cm  1  311818-US



HCPCS code C1849 – Skin substitute, synthetic

Effective April 1, 2022 the HCPCS Workgroup created a new HCPCS code, C1849 for “Skin substitute, synthetic, resorbable, per square centimeter”. CMS has designated C1849 as a low cost skin substitute under the Medicare Outpatient Prospective Payment System.
2022 SUPRATHEL and SUPRA SDRM Billing Guide.

For more detailed information please contact our customer service
General Inquiries & Product Trials: INFO.USA@POLYMEDICS.COM
Reimbursement & Billing Questions: REIMBURSEMENT.USA@POLYMEDICS.COM